Cargando…

Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: A seven-year analysis

Sapropterin dihydrochloride has been approved for the treatment of hyperphenylalaninemia in infants and young children with phenylketonuria (PKU). Sapropterin can reduce phenylalanine (Phe) levels in tetrahydrobiopterin (BH4)-responsive patients, potentially preventing the intellectual impairment ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waisbren, Susan, Burton, Barbara K., Feigenbaum, Annette, Konczal, Laura L., Lilienstein, Joshua, McCandless, Shawn E., Rowell, Richard, Sanchez-Valle, Amarilis, Whitehall, Kaleigh B., Longo, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684368/ https://www.ncbi.nlm.nih.gov/pubmed/33485801 http://dx.doi.org/10.1016/j.ymgme.2021.01.001

Ejemplares similares

New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
por: Harding, Cary O
Publicado: (2010)

Sapropterin for phenylketonuria: A Japanese post‐marketing surveillance study
por: Tamura, Mina, et al.
Publicado: (2022)

Pretreatment cognitive and neural differences between sapropterin dihydrochloride responders and non-responders with phenylketonuria
por: Hawks, Zoë, et al.
Publicado: (2017)

Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride
por: Douglas, Teresa D, et al.
Publicado: (2013)

A Prospective Population Pharmacokinetic Analysis of Sapropterin Dihydrochloride in Infants and Young Children with Phenylketonuria
por: Qi, Yulan, et al.
Publicado: (2014)

Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: A meta‐analysis of randomized controlled trials
por: Qu, Jinghan, et al.
Publicado: (2019)

First Japanese case of maternal phenylketonuria treated with sapropterin dihydrochloride and the normal growth and development of the child
por: Nyuzuki, Hiromi, et al.
Publicado: (2019)

A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation
por: Ficicioglu, Can, et al.
Publicado: (2013)

Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial
por: Muntau, Ania C., et al.
Publicado: (2021)

Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics()
por: Adams, Darius, et al.
Publicado: (2021)

Impact on Diet Quality and Burden of Care in Sapropterin Dihydrochloride Use in Children with Phenylketonuria: A 6 Month Follow-Up Report
por: Gama, Maria Inês, et al.
Publicado: (2023)

Sapropterin Dihydrochloride Mixed With Common Foods and Beverages
por: Jurecki, Elaina R., et al.
Publicado: (2014)

Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data
por: Lah, Melissa, et al.
Publicado: (2022)

Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria
por: Longo, Nicola, et al.
Publicado: (2018)

A novel cause of emergent hyperammonemia: Cryptococcal fungemia and meningitis
por: Hannah, William B., et al.
Publicado: (2021)

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice
por: Schmitz, Katja, et al.
Publicado: (2021)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
por: Scudellaro, Emanuela, et al.
Publicado: (2020)

Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness
por: Chen, Huey-Fen, et al.
Publicado: (2021)

Improved attention linked to sustained phenylalanine reduction in adults with early‐treated phenylketonuria
por: Bilder, Deborah A., et al.
Publicado: (2021)

Treatment adherence during childhood in individuals with phenylketonuria: Early signs of treatment discontinuation
por: García, María Ignacia, et al.
Publicado: (2017)

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study
por: Frye, R E, et al.
Publicado: (2013)

Life-threatening presentations of propionic acidemia due to the Amish PCCB founder variant
por: Hannah, William B., et al.
Publicado: (2019)

Classical phenylketonuria presenting as maternal PKU syndrome in the offspring of an intellectually normal woman
por: Alghamdi, Malak Ali, et al.
Publicado: (2023)

Reforming birth registration law in England and Wales?
por: McCandless, Julie
Publicado: (2017)

Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria
por: Zori, Roberto, et al.
Publicado: (2019)

Sapropterin Treatment Prevents Congenital Heart Defects Induced by Pregestational Diabetes Mellitus in Mice
por: Engineer, Anish, et al.
Publicado: (2018)

Conducta y desarrollo del niño
por: McCandless, Boyd R.
Publicado: (1981)

Placenta Praevia — a Fatal Case
por: McCandless, A. B.
Publicado: (1873)

A reply to ‘Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study'
por: Fluegge, K
Publicado: (2016)

Phenylketonuria
por: Hudson, Frederick
Publicado: (1969)

The Global Prader–Willi Syndrome Registry: Development, Launch, and Early Demographics
por: Bohonowych, Jessica, et al.
Publicado: (2019)

Sapropterin dihydrochloride therapy in dihydropteridine reductase deficiency: Insight from the first case with molecular diagnosis in Brazil
por: Lourenço, Charles Marques, et al.
Publicado: (2021)

An exceptional Albanian family with seven children presenting with dysmorphic features and mental retardation: maternal phenylketonuria
por: Knerr, Ina, et al.
Publicado: (2005)

Long-term follow-up of patients with phenylketonuria treated with tetrahydrobiopterin: a seven years experience
por: Scala, Iris, et al.
Publicado: (2015)

Probabilistic Approaches to Better Quantifying the Results of Epidemiologic Studies
por: Gustafson, Paul, et al.
Publicado: (2010)

The Craft of Contemporary Commercial Music
por: McCandless, Greg, et al.
Publicado: (2017)

HIV Coreceptors and Their Roles in Leukocyte Trafficking During Neuroinflammatory Diseases
por: Klein, Robyn S., et al.
Publicado: (2009)

Exploring the Potential of Statistical Modeling to Retrieve the Cloud Base Height from Geostationary Satellites: Applications to the ABI Sensor on Board of the GOES-R Satellite Series
por: Jiménez, Pedro A., et al.
Publicado: (2021)

Examining the Potential of a Random Forest Derived Cloud Mask from GOES-R Satellites to Improve Solar Irradiance Forecasting
por: McCandless, Tyler, et al.
Publicado: (2020)

Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries
por: Bosch, Annet M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9a5qsbignmrt21ig1c92ovg322